Michael W Parsons

Dr. Michael W Parsons

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
AAAyal A Aizer
Ayal A Aizer
NLNayan Lamba
Nayan Lamba
MAManmeet S Ahluwalia
Manmeet S Ahluwalia
KAKenneth Aldape
Kenneth Aldape
ABAdrienne Boire
Adrienne Boire
PWPatrick Y Wen
Patrick Y Wen
Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is known about brain metastases than cancer-related entities of similar incidence. Advances in oncologic care have heightened the importance of intracranial management. Here, in this consensus review supported by the Society for Neuro-Oncology (SNO), we review the landscape of brain metastases with particular attention to management approaches and ongoing efforts with potential to shape future paradigms of care. Each coauthor carried an area of expertise within the field of brain metastases and initially composed, edited, or reviewed their specific subsection of interest. After each subsection was accordingly written, multiple drafts of the manuscript were circulated to the entire list of authors for group discussion and feedback. The hope is that the these consensus guidelines will accelerate progress in the understanding and management of patients with brain metastases, and highlight key areas in need of further exploration that will lead to dedicated trials and other research investigations designed to advance the field.

6 May 2021 in Journal of the International Neuropsychological Society
Verified
Journal Article
Open access
PDF file
MPMichael W Parsons
Michael W Parsons
MGMelissa M. Gardner
Melissa M. Gardner
JSJanet C. Sherman
Janet C. Sherman
KPKathryn Pasquariello
Kathryn Pasquariello
JGJulie A. Grieco
Julie A. Grieco
SMSarah M. Mancuso
Sarah M. Mancuso
Objective:: Neuropsychological assessment via video conferencing has been proposed during the COVID-19 pandemic. Existing literature has demonstrated feasibility and acceptance of neuropsychological measures administered by videoconference, although few studies have examined feasibility and patient acceptance of TNP visits directly to patients’ homes (DTH-TNP).Methods:: We modified a previously published patient satisfaction survey for DTH-TNP and developed a clinician feasibility survey to examine experiences during DTH-TNP.Results:: Seventy-two patients (age range: preschool-geriatric) evaluated by DTH-TNP for cognitive problems at an academic medical center responded to voluntary surveys between April 20, 2020, and August 19, 2020, and 100% indicated satisfaction. Fifty-nine percent of patients reported limitations (e.g., technological concern) during the appointment. 134 clinician surveys were collected and indicated that clinicians achieved the goal of their appointment in 90% of encounters.Conclusions:: These qualitative data suggest that patients and clinicians found DTH-TNP to be satisfactory during the COVID-19 pandemic, while also recognizing limitations of the practice. These results are limited in that voluntary surveys are subject to bias. They support the growing body of literature suggesting that DTH-TNP provides a valuable service, though additional research to establish reliability and validity is needed.

6 August 2015 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
Manmeet S AhluwaliaManmeet S Ahluwalia
Manmeet S Ahluwalia
SCSamuel T. Chao
Samuel T. Chao
MPMichael W Parsons
Michael W Parsons
JSJohn H. Suh
John H. Suh
DWDing Wang
Ding Wang
DPDavid Peereboom
David Peereboom

27 November 2021 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
MPMichael W Parsons
Michael W Parsons
KPKatherine B Peters
Katherine B Peters
SFScott R Floyd
Scott R Floyd
PBPaul Brown
Paul Brown
JWJeffrey S Wefel
Jeffrey S Wefel
Neurocognitive function (NCF) deficits are common in patients with brain metastases, occurring in up to 90% of cases. NCF deficits may be caused by tumor-related factors and/or treatment for the metastasis, including surgery, radiation therapy, chemotherapy, and immunotherapy. In recent years, strategies to prevent negative impact of treatments and ameliorate cognitive deficits for patients with brain tumors have gained momentum. In this review, we report on research that has established the efficacy of preventative and rehabilitative therapies for NCF deficits in patients with brain metastases. Surgical strategies include the use of laser interstitial thermal therapy and intraoperative mapping. Radiotherapy approaches include focal treatments such as stereotactic radiosurgery and tailored approaches such as hippocampal avoidant whole-brain radiotherapy (WBRT). Pharmacologic options include use of the neuroprotectant memantine to reduce cognitive decline induced by WBRT and incorporation of medications traditionally used for attention and memory problems. Integration of neuropsychology into the care of patients with brain metastases helps characterize cognitive patterns, educate patients and families regarding their management, and guide rehabilitative therapies. These and other strategies will become even more important for long-term survivors of brain metastases as treatment options improve.

20 March 2023 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
MPMichael W Parsons
Michael W Parsons
DSDavid S. Sabsevitz
David S. Sabsevitz

8 April 2021 in Neuro-Oncology Practice
Verified
Journal Article
Open access
PDF file
MGMelissa M Gardner
Melissa M Gardner
FAFarah J Aslanzadeh
Farah J Aslanzadeh
GZGiuliana V Zarrella
Giuliana V Zarrella
SBSarah E Braun
Sarah E Braun
ALAshlee R Loughan
Ashlee R Loughan
MPMichael W Parsons
Michael W Parsons
Background: The COVID-19 pandemic induced rapid adoption of telemedicine services for neuro-oncology patients at an increased risk of infection. Neuropsychological assessment is important to neuro-oncology care yet challenging to complete outside of a structured testing environment. Teleneuropsychology (TNP) has been explored in limited populations and proven feasible and reliable. Conducting TNP visits directly to patients’ home (DTH) had minimal prior study. Methods: We used two voluntary surveys to examine acceptance (patients) and feasibility (providers) of DTH-TNP at two regionally diverse medical institutions providing neuropsychological services to neuro-oncology patients from April to September 2020. Results: A total of 119 patients were scheduled during the study period, 79 of whom completed neuropsychological testing via DTH-TNP. Neuropsychology providers completed surveys on 68 of these encounters (86%). In 98% of cases, neuropsychologists were able to achieve or partially achieve the individually defined goals of their assessment. Common problems reported included patient dysregulation (16%) and slow/unreliable internet (15%). Of the 52 patients who responded, 98% were satisfied with the DTH-TNP experience, and 92% would recommend the virtual visit to others. All respondents felt understood by the examiner (100%) and the majority denied technical difficulties (90%), communication challenges (94%), or privacy concerns (98%). Patients reported reduced risk of infection and saved travel time as favorable aspects of DTH-TNP. Conclusions: These preliminary results suggest neuro-oncology patients find DTH-TNP acceptable and neuropsychologists find it a feasible practice, while also recognizing its limitations. Results suggest that further study of DTH-TNP (eg, reliability, validity) for neuro-oncology patients is warranted.